Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
:
Patient Education / Summary The following patient-friendly summary may be adapted for use in patient education materials, discharge instructions, or practice communications
Advantages: Localized delivery to target tissue (skin, scalp) Non-invasive Lower systemic exposure Well-tolerated with established safety record in cosmeceuticals Limitations: Limited dermal penetration (molecular weight ~340 Da near the cutoff for transdermal absorption) No systemic anti-aging or anti-inflammatory effects Efficacy dependent on formulation vehicle (liposomal carriers significantly improve penetration) GHK-Cu Injection (Subcutaneous) GHK-Cu injection is explored in research settings for systemic administration
10.1038/s41587-019-0344-3 94 OrreL
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Age-dependent accumulation of oligomeric SNCA/-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: Role for therapeutic activation of chaperone-mediated autophagy (CMA)
